Avista backs eMolecules as pharma seeks to simplify supply chain
Accounting for eMolecules and its pending investment in French drugmaker Cooper, Avista Fund V is 50% deployed.
31 March 2021•3 mins read
Accounting for eMolecules and its pending investment in French drugmaker Cooper, Avista Fund V is 50% deployed.
Apollo funds complete minority investment in Alpine-backed Apex Service Partners
7 hours ago · 2 mins read
Rainier Partners invests in Texas auto insurance MGA platform Apex
13 hours ago · 2 mins read
Stonepeak completes carve-out of BMO’s transportation and vendor finance units
13 hours ago · 2 mins read
Trivest-backed Wheelhouse buys California and Utah garage door firm All Star
13 hours ago · 1 min read
Water Street and JLL Partners’ Eversana announces acquisition of London’s Estima Scientific
15 hours ago · 1 min read
DPE’s Mehler Systems to acquire majority stake in Bulgaria’s MARS Armor
16 hours ago · 1 min read
Speyside Equity buys Midwest steel tubing and building products maker Tapco
29 October 2026 · 2 mins read
